191 related articles for article (PubMed ID: 11285156)
41. [HIV, HCV, HBV and syphilis surveillance among blood donors in Germany 2008-2010].
Offergeld R; Ritter S; Hamouda O
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2012 Aug; 55(8):907-13. PubMed ID: 22842883
[TBL] [Abstract][Full Text] [Related]
42. Seroprevalence and diagnosis of HIV, HBV, HCV and syphilis infections among blood donors.
Tafesse TB; Gebru AA; Gobalee S; Belay GD; Belew MT; Ataro D; Ebrahim BA; Shebeshi GM; Yimam Y
Hum Antibodies; 2017; 25(1-2):39-55. PubMed ID: 28009328
[TBL] [Abstract][Full Text] [Related]
43. [HIV, HCV, HBV and syphilis infections among blood donors in Germany 2005. Report from the Robert Koch Institute in accordance with Article 22 of the Transfusion Act].
Offergeld R; Ritter S; Hamouda O
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2007 Oct; 50(10):1221-31. PubMed ID: 17924066
[TBL] [Abstract][Full Text] [Related]
44. Is there a risk of transfusion-transmissible infections after percutaneous needle treatments in blood donors? A systematic review and meta-analysis.
Van Remoortel H; Moorkens D; Avau B; Compernolle V; Vandekerckhove P; De Buck E
Vox Sang; 2019 May; 114(4):297-309. PubMed ID: 30972765
[TBL] [Abstract][Full Text] [Related]
45. Retesting of bone donors 2 months after donation guarantees sufficient safety of bone allografts.
Hirn MY; Krusius T
Acta Orthop Scand; 1998 Dec; 69(6):566-9. PubMed ID: 9930098
[TBL] [Abstract][Full Text] [Related]
46. Transmission of hepatitis C virus infection through tattooing and piercing: a critical review.
Tohme RA; Holmberg SD
Clin Infect Dis; 2012 Apr; 54(8):1167-78. PubMed ID: 22291098
[TBL] [Abstract][Full Text] [Related]
47. [HCV infection from the viewpoint of medical law].
Bálint T; Halász S; Lengyel G; Németh E; Fehér J
Orv Hetil; 2006 May; 147(20):937-43. PubMed ID: 16776049
[TBL] [Abstract][Full Text] [Related]
48. [Present status of infectious diseases transmitted by blood transfusion and the preventive measures].
Shimoyama T
Masui; 1999; 48 Suppl():S33-40. PubMed ID: 10785958
[No Abstract] [Full Text] [Related]
49. Two decades of risk factors and transfusion-transmissible infections in Dutch blood donors.
Slot E; Janssen MP; Marijt-van der Kreek T; Zaaijer HL; van de Laar TJ
Transfusion; 2016 Jan; 56(1):203-14. PubMed ID: 26355711
[TBL] [Abstract][Full Text] [Related]
50. Effectiveness of mandatory transmissible diseases screening in Indian blood donors.
Choudhury N; Ramesh V; Saraswat S; Naik S
Indian J Med Res; 1995 Jun; 101():229-32. PubMed ID: 7672831
[TBL] [Abstract][Full Text] [Related]
51. Trends in incidence and prevalence of major transfusion-transmissible viral infections in US blood donors, 1991 to 1996. Retrovirus Epidemiology Donor Study (REDS).
Glynn SA; Kleinman SH; Schreiber GB; Busch MP; Wright DJ; Smith JW; Nass CC; Williams AE
JAMA; 2000 Jul; 284(2):229-35. PubMed ID: 10889598
[TBL] [Abstract][Full Text] [Related]
52. Significant background rates of HBV and HCV infections in patients and risks of blood transfusion from donors with low anti-HBc titres or high anti-HBc titres with high anti-HBs titres in Japan: a prospective, individual NAT study of transfusion-transmitted HBV, HCV and HIV infections.
Tani Y; Aso H; Matsukura H; Tadokoro K; Tamori A; Nishiguchi S; Yoshizawa H; Shibata H;
Vox Sang; 2012 May; 102(4):285-93. PubMed ID: 22082342
[TBL] [Abstract][Full Text] [Related]
53. The efficacy of individual-donation and minipool testing to detect low-level hepatitis B virus DNA in Taiwan.
Yang MH; Li L; Hung YS; Hung CS; Allain JP; Lin KS; Tsai SJ
Transfusion; 2010 Jan; 50(1):65-74. PubMed ID: 19709394
[TBL] [Abstract][Full Text] [Related]
54. Seroprevalence of infectious markers & their trends in blood donors in a hospital based blood bank in north India.
Makroo RN; Hegde V; Chowdhry M; Bhatia A; Rosamma NL
Indian J Med Res; 2015 Sep; 142(3):317-22. PubMed ID: 26458348
[TBL] [Abstract][Full Text] [Related]
55. Prevention of transmission of hepatitis B, hepatitis C and human immunodeficiency virus infections through blood transfusion by anti-HBc testing.
Busch MP
Vox Sang; 1998; 74 Suppl 2():147-54. PubMed ID: 9704438
[No Abstract] [Full Text] [Related]
56. [Risk of infection transmission by blood components].
Kubanek B; Cardoso M; Glück D; Koerner K
Infusionsther Transfusionsmed; 1993 Apr; 20(1-2):54-9. PubMed ID: 8504243
[TBL] [Abstract][Full Text] [Related]
57. Diagnostic accuracy of blood centers in the screening of blood donors for viral markers.
Dogbe EE; Arthur F
Pan Afr Med J; 2015; 20():119. PubMed ID: 26090067
[TBL] [Abstract][Full Text] [Related]
58. Hepatitis B, syphilis, and human immunodeficiency virus: are different approaches to prenatal screening justified?
Grimes RM; Richards EP; Rathbun KC
Pediatr AIDS HIV Infect; 1997 Apr; 8(2):98-101. PubMed ID: 11361783
[No Abstract] [Full Text] [Related]
59. Prevalence of human immunodeficiency virus, hepatitis C virus, hepatitis B virus and syphilis among individuals attending anonymous testing for HIV in Luanda, Angola.
Guimarães Nebenzahl H; Lopes A; Castro R; Pereira F
S Afr Med J; 2013 Jan; 103(3):186-8. PubMed ID: 23472697
[TBL] [Abstract][Full Text] [Related]
60. Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus.
Hourfar MK; Jork C; Schottstedt V; Weber-Schehl M; Brixner V; Busch MP; Geusendam G; Gubbe K; Mahnhardt C; Mayr-Wohlfart U; Pichl L; Roth WK; Schmidt M; Seifried E; Wright DJ;
Transfusion; 2008 Aug; 48(8):1558-66. PubMed ID: 18466173
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
